Targeted deletion of MMP-9 attenuates myocardial contractile dysfunction in heart failure
Language English Country Czech Republic Media print-electronic
Document type Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
Grant support
HL 71010
NHLBI NIH HHS - United States
HL 74185
NHLBI NIH HHS - United States
PubMed
17552869
DOI
10.33549/physiolres.931221
PII: 1221
Knihovny.cz E-resources
- MeSH
- Acetylcholine pharmacology MeSH
- Enzyme Activation MeSH
- Arteriovenous Shunt, Surgical MeSH
- Bradykinin pharmacology MeSH
- Endothelial Cells drug effects enzymology MeSH
- Phenotype MeSH
- Ventricular Function, Left * drug effects MeSH
- Myocardial Contraction * drug effects MeSH
- Matrix Metalloproteinase 9 deficiency genetics metabolism MeSH
- Disease Models, Animal MeSH
- Myocardium enzymology MeSH
- Mice, Knockout MeSH
- Mice MeSH
- Nitroprusside pharmacology MeSH
- Heart Ventricles enzymology physiopathology MeSH
- Heart Failure enzymology physiopathology MeSH
- Dose-Response Relationship, Drug MeSH
- Animals MeSH
- Check Tag
- Male MeSH
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Research Support, N.I.H., Extramural MeSH
- Names of Substances
- Acetylcholine MeSH
- Bradykinin MeSH
- Matrix Metalloproteinase 9 MeSH
- Mmp9 protein, mouse MeSH Browser
- Nitroprusside MeSH
Chronic volume overload (VO) on the left ventricle (LV) augments redox stress and activates matrix metalloproteinase (MMP) which causes the endocardial endothelial-myocyte (EM) disconnection leading to myocardial contractile dysfunction. VO-induced MMP-9 activation impairs cardiac functions, in part by endothelial endocardial apoptosis, but the role of MMP-9 on EM functions remains obscure. We conjecture that chronic VO activates MMP-9 and causes EM uncoupling. Arteriovenous fistula (AVF) was created in genetically identical wild type (WT) mice (FVB/NJ) and MMP-9 knockout mice (MMP-9KO, FVB.Cg-MMP9(tm1Tvu)/J). Sham-operated mice were used as controls. Before experimentation the phenotype analysis of MMP-9KO mice was carried out. In-gel-gelatin zymography for MMP-9 activation was performed on LV homogenates. The EM functions were determined on LV rings using tissue myobath. We report a decrease in MMP-9 activity in left ventricular myocardial extracts in MMP-9 deficient mice after AVF. The responses to drugs affecting cardiac functions (acetylcholine (Ach), nitroprusside and bradykinin) were attenuated in AVF mice suggesting the impairment of EM coupling. Interestingly, the EM functions were restored in the MMP-9 deficient mice after AVF. We suggest a direct cause-and-effect relationship between MMP-9 activation and EM uncoupling in LV myocardium after chronic VO and the possible involvement of MMP-9 in myocardial contractile performance.
References provided by Crossref.org